Form 8-K - Current report:
SEC Accession No. 0001193125-25-122156
Filing Date
2025-05-19
Accepted
2025-05-19 09:09:57
Documents
52
Period of Report
2025-05-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d863812d8k.htm   iXBRL 8-K 51706
2 EX-99.1 d863812dex991.htm EX-99.1 20584
3 EX-99.2 d863812dex992.htm EX-99.2 25549
4 EX-99.3 d863812dex993.htm EX-99.3 45550
8 GRAPHIC g863812ex99_3p10g1.jpg GRAPHIC 254573
9 GRAPHIC g863812ex99_3p11g1.jpg GRAPHIC 123189
10 GRAPHIC g863812ex99_3p12g1.jpg GRAPHIC 437776
11 GRAPHIC g863812ex99_3p13g1.jpg GRAPHIC 459558
12 GRAPHIC g863812ex99_3p14g1.jpg GRAPHIC 343658
13 GRAPHIC g863812ex99_3p15g1.jpg GRAPHIC 126206
14 GRAPHIC g863812ex99_3p16g1.jpg GRAPHIC 383370
15 GRAPHIC g863812ex99_3p17g1.jpg GRAPHIC 272177
16 GRAPHIC g863812ex99_3p18g1.jpg GRAPHIC 148939
17 GRAPHIC g863812ex99_3p19g1.jpg GRAPHIC 474595
18 GRAPHIC g863812ex99_3p1g1.jpg GRAPHIC 178892
19 GRAPHIC g863812ex99_3p20g1.jpg GRAPHIC 332605
20 GRAPHIC g863812ex99_3p21g1.jpg GRAPHIC 376633
21 GRAPHIC g863812ex99_3p22g1.jpg GRAPHIC 115196
22 GRAPHIC g863812ex99_3p23g1.jpg GRAPHIC 443274
23 GRAPHIC g863812ex99_3p24g1.jpg GRAPHIC 333849
24 GRAPHIC g863812ex99_3p25g1.jpg GRAPHIC 344335
25 GRAPHIC g863812ex99_3p26g1.jpg GRAPHIC 141687
26 GRAPHIC g863812ex99_3p27g1.jpg GRAPHIC 418535
27 GRAPHIC g863812ex99_3p28g1.jpg GRAPHIC 418337
28 GRAPHIC g863812ex99_3p29g1.jpg GRAPHIC 255763
29 GRAPHIC g863812ex99_3p2g1.jpg GRAPHIC 755361
30 GRAPHIC g863812ex99_3p30g1.jpg GRAPHIC 125980
31 GRAPHIC g863812ex99_3p31g1.jpg GRAPHIC 324264
32 GRAPHIC g863812ex99_3p32g1.jpg GRAPHIC 502851
33 GRAPHIC g863812ex99_3p33g1.jpg GRAPHIC 478320
34 GRAPHIC g863812ex99_3p34g1.jpg GRAPHIC 125064
35 GRAPHIC g863812ex99_3p35g1.jpg GRAPHIC 262192
36 GRAPHIC g863812ex99_3p36g1.jpg GRAPHIC 372209
37 GRAPHIC g863812ex99_3p3g1.jpg GRAPHIC 357085
38 GRAPHIC g863812ex99_3p4g1.jpg GRAPHIC 338195
39 GRAPHIC g863812ex99_3p5g1.jpg GRAPHIC 413663
40 GRAPHIC g863812ex99_3p6g1.jpg GRAPHIC 356339
41 GRAPHIC g863812ex99_3p7g1.jpg GRAPHIC 364829
42 GRAPHIC g863812ex99_3p8g1.jpg GRAPHIC 386957
43 GRAPHIC g863812ex99_3p9g1.jpg GRAPHIC 217648
44 GRAPHIC g863812g0518222359583.jpg GRAPHIC 2916
  Complete submission text file 0001193125-25-122156.txt   16514054

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA prme-20250516.xsd EX-101.SCH 2869
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE prme-20250516_lab.xml EX-101.LAB 17979
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prme-20250516_pre.xml EX-101.PRE 11271
54 EXTRACTED XBRL INSTANCE DOCUMENT d863812d8k_htm.xml XML 3627
Mailing Address 60 FIRST ST. CAMBRIDGE MA 02141
Business Address 60 FIRST ST. CAMBRIDGE MA 02141 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41536 | Film No.: 25961795
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)